Home Newsletters Hepatic Cell News Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to...

Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to the UK Medicines and Healthcare Products Regulatory Agency

0
Shanghai Junshi Biosciences Co., Ltd announced that the company has submitted a marketing authorization application to the United Kingdom’s Medicines and Healthcare products Regulatory Agency for toripalimab
[Shanghai Junshi Biosciences Co., Ltd]
Press Release
Exit mobile version